The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Noeurostegine ID: ALA1682493
Chembl Id: CHEMBL1682493
PubChem CID: 45102053
Max Phase: Preclinical
Molecular Formula: C8H15NO4
Molecular Weight: 189.21
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Synonyms: Noeurostegine | Noeurostegine|CHEMBL1682493|BDBM50337386
Canonical SMILES: OC[C@@H]1[C@@H](O)[C@H](O)[C@]2(O)CC[C@H]1N2
Standard InChI: InChI=1S/C8H15NO4/c10-3-4-5-1-2-8(13,9-5)7(12)6(4)11/h4-7,9-13H,1-3H2/t4-,5+,6+,7-,8+/m0/s1
Standard InChI Key: NLSPHUUFXPUPJJ-FMGWEMOISA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 189.21Molecular Weight (Monoisotopic): 189.1001AlogP: -2.23#Rotatable Bonds: 1Polar Surface Area: 92.95Molecular Species: BASEHBA: 5HBD: 5#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 5#RO5 Violations (Lipinski): 0CX Acidic pKa: 12.22CX Basic pKa: 8.83CX LogP: -2.15CX LogD: -3.60Aromatic Rings: 0Heavy Atoms: 13QED Weighted: 0.32Np Likeness Score: 2.73
References 1. Rasmussen TS, Allman S, Twigg G, Butters TD, Jensen HH.. (2011) Synthesis of N-alkylated noeurostegines and evaluation of their potential as treatment for Gaucher's disease., 21 (5): [PMID:21292481 ] [10.1016/j.bmcl.2010.12.106 ]